Seer, Inc.

The current price of SEER is $1.63 — it has decreased by 4.12% since the previous close. Data as of Nov 5, 2026.

SEER is down 13.76% over the past week, down 30.04% over the past month and down 24.88% over the past year. The price is below its 200-day moving average of $1.92.

Analysts' average 12-month price target for SEER is $4.00, which implies 145.40% upside from the current price. Individual estimates range from $4.00 to $4.00.

Of the 2 analysts covering Seer, Inc., 2 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

Seer, Inc. has a market capitalization of $90.26M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Seer, Inc. posted a loss of $0.31 per share against an estimate of -$0.27, missing expectations by 14.81%. Upcoming reports are listed in the earnings calendar.

Seer, Inc. reported revenue of $3.1M in its most recent quarter, which has decreased by 23.43% compared with the same quarter a year earlier. Analysts had expected $3.55M.

Seer, Inc. has not paid any dividends over the past year.

Companies most comparable to Seer, Inc. include Kymera Therapeutics, Inc., Pharvaris N.V., Nurix Therapeutics, Inc., Mineralys Therapeutics, Inc. and ORIC Pharmaceuticals, Inc.

In the latest trading session SEER moved between $1.62 and $1.71, a range of 5.52% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Seer, Inc. shows a strong sell rating today and a strong sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Seer, Inc. is sell. Technical ratings are indicators, not investment advice.

Over the past 52 weeks SEER has traded between $1.55 and $2.38. The current price is 31.51% below its 52-week high.